Published in J Virol on February 18, 2009
Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathog (2010) 1.63
Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J Virol (2009) 1.46
Forty-five years of Marburg virus research. Viruses (2012) 1.34
Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antiviral Res (2011) 1.24
Structural basis for Marburg virus VP35-mediated immune evasion mechanisms. Proc Natl Acad Sci U S A (2012) 1.18
Filoviral immune evasion mechanisms. Viruses (2011) 1.10
Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch Virol (2013) 1.10
Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation. J Virol (2014) 0.83
Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread. J Infect Dis (2011) 0.83
Sequence variability in viral genome non-coding regions likely contribute to observed differences in viral replication amongst MARV strains. Virology (2013) 0.76
Marburg Virus Reverse Genetics Systems. Viruses (2016) 0.75
The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol (1993) 6.38
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol (2006) 4.01
Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res (1993) 3.89
Marburg-virus disease in Kenya. Lancet (1982) 3.79
Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA. Proc Natl Acad Sci U S A (1994) 3.13
Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science (2001) 3.08
Promoter elements in the influenza vRNA terminal structure. RNA (1996) 2.97
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol (2002) 2.58
Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res (1992) 2.29
Paramyxovirus mRNA editing, the "rule of six" and error catastrophe: a hypothesis. J Gen Virol (2005) 2.19
Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol (2004) 2.09
Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol (2002) 1.71
Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2003) 1.56
Polyploid measles virus with hexameric genome length. EMBO J (2002) 1.55
The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication. J Virol (1998) 1.52
Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six. Virology (1997) 1.48
Phosphorylation of VP30 impairs ebola virus transcription. J Biol Chem (2002) 1.47
The Marburg virus outbreak of 1967 and subsequent episodes. Curr Top Microbiol Immunol (1999) 1.41
Sequence and structural elements at the 3' terminus of bovine viral diarrhea virus genomic RNA: functional role during RNA replication. J Virol (1999) 1.38
Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. Proc Natl Acad Sci U S A (2007) 1.37
Termini of all mRNA species of Marburg virus: sequence and secondary structure. Virology (1996) 1.36
Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells. J Virol (1996) 1.34
Complementarity, sequence and structural elements within the 3' and 5' non-coding regions of the Bunyamwera orthobunyavirus S segment determine promoter strength. J Gen Virol (2004) 1.33
Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J Virol (2005) 1.32
Role of Ebola virus VP30 in transcription reinitiation. J Virol (2008) 1.28
RNA polymerase I-driven minigenome system for Ebola viruses. J Virol (2005) 1.27
Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3. Virology (2000) 1.26
RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (CGNNNN) sequence motif. J Virol (1999) 1.24
Mapping the transcription and replication promoters of respiratory syncytial virus. J Virol (2002) 1.20
The efficiency of Sendai virus genome replication: the importance of the RNA primary sequence independent of terminal complementarity. Virology (1996) 1.19
Unravelling the complexities of respiratory syncytial virus RNA synthesis. J Gen Virol (2006) 1.17
Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30. J Virol (2006) 1.15
The Ebola virus genomic replication promoter is bipartite and follows the rule of six. J Virol (2005) 1.14
Identification of internal sequences in the 3' leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity. J Virol (2005) 1.12
Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus. J Virol (2000) 1.11
Ebola virus VP30 is an RNA binding protein. J Virol (2007) 1.04
Ebola virus defective interfering particles and persistent infection. Virology (1999) 1.03
Inhibition of Marburg virus protein expression and viral release by RNA interference. J Gen Virol (2005) 1.01
Analysis of RNA secondary structure in replication of human parainfluenza virus type 3. Virology (2000) 0.94
An internal element of the measles virus antigenome promoter modulates replication efficiency. Virus Res (2004) 0.93
Analysis of the role of predicted RNA secondary structures in Ebola virus replication. Virology (2003) 0.91
Support plasmids and support proteins required for recovery of recombinant respiratory syncytial virus. Virology (1999) 0.91
Nature of a paramyxovirus replication promoter influences a nearby transcription signal. J Gen Virol (2005) 0.88
Mapping of the RNA promoter of Newcastle disease virus. Virology (2005) 0.87
Competition between the Sendai virus N mRNA start site and the genome 3'-end promoter for viral RNA polymerase. J Virol (2003) 0.85
Cis-acting elements in the antigenomic promoter of Nipah virus. J Gen Virol (2007) 0.81
The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol (2003) 4.73
Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One (2008) 2.45
Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog (2006) 2.26
Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J Virol (2006) 2.14
Rapid detection protocol for filoviruses. J Clin Virol (2004) 2.13
Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells. PLoS Biol (2011) 2.02
Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol (2002) 1.71
Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathog (2010) 1.63
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob Agents Chemother (2006) 1.63
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol (2012) 1.59
Phosphorylation of VP30 impairs ebola virus transcription. J Biol Chem (2002) 1.47
Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J Virol (2009) 1.46
A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire. Virology (2005) 1.40
Forty-five years of Marburg virus research. Viruses (2012) 1.34
The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes. Nucleic Acids Res (2011) 1.30
Ebola virus transcription activator VP30 is a zinc-binding protein. J Virol (2003) 1.29
Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Arch Virol (2014) 1.27
Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. J Biol Chem (2003) 1.24
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol (2013) 1.16
Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30. J Virol (2006) 1.15
The Ebola virus genomic replication promoter is bipartite and follows the rule of six. J Virol (2005) 1.14
Identification of phosphorylation-dependent interaction partners of the adapter protein ADAP using quantitative mass spectrometry: SILAC vs (18)O-labeling. J Proteome Res (2010) 1.12
Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch Virol (2013) 1.10
Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity. J Virol (2008) 1.06
Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain. J Mol Biol (2010) 1.04
The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. J Clin Virol (2004) 1.01
Intracellular events and cell fate in filovirus infection. Viruses (2011) 1.01
Electron tomography reveals the steps in filovirus budding. PLoS Pathog (2010) 0.97
Quantitative proteomics analysis of detergent-resistant membranes from chemical synapses: evidence for cholesterol as spatial organizer of synaptic vesicle cycling. Mol Cell Proteomics (2006) 0.95
The cell surface proteome of Entamoeba histolytica. Mol Cell Proteomics (2013) 0.89
The Marburg virus surface protein GP is phosphorylated at its ectodomain. Virology (2002) 0.89
The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals. Virology (2013) 0.89
Multivalent binding of formin-binding protein 21 (FBP21)-tandem-WW domains fosters protein recognition in the pre-spliceosome. J Biol Chem (2011) 0.88
Residential exposure to overhead high-voltage lines and the risk of testicular cancer: results of a population-based case-control study in Hamburg (Germany). Int Arch Occup Environ Health (2004) 0.87
The cellular protein lyric interacts with HIV-1 Gag. J Virol (2011) 0.84
Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread. J Infect Dis (2011) 0.83
Evaluation of ambient air concentrations of polycyclic aromatic hydrocarbons in Germany from 1990 to 1998. J Expo Anal Environ Epidemiol (2002) 0.82
CIN85 interacting proteins in B cells-specific role for SHIP-1. Mol Cell Proteomics (2011) 0.82
Site-specifically phosphorylated lysine peptides. J Am Chem Soc (2014) 0.82
Ebola virus does not block apoptotic signaling pathways. J Virol (2013) 0.82
Analysis of rotavirus non-structural protein NSP5 by mass spectrometry reveals a complex phosphorylation pattern. Virus Res (2009) 0.81
Relative quantification of erythropoietin receptor-dependent phosphoproteins using in-gel 18O-labeling and tandem mass spectrometry. Rapid Commun Mass Spectrom (2005) 0.81
Vero cells as a model to study the effects of adenoviral gene delivery vectors on the RNAi system in context of viral infection. J Innate Immun (2009) 0.80
Ebola virus VP35 induces high-level production of recombinant TPL-2-ABIN-2-NF-κB1 p105 complex in co-transfected HEK-293 cells. Biochem J (2013) 0.79
Analysis of phosphorylation-dependent protein-protein interactions of histone h3. ACS Chem Biol (2014) 0.78
A strategy for enrichment of claudins based on their affinity to Clostridium perfringens enterotoxin. BMC Mol Biol (2009) 0.78
Probing the acetylation code of histone H4. Proteomics (2013) 0.78
Phosphoprotein profiling of erythropoietin receptor- dependent pathways using different proteomic strategies. Proteomics (2005) 0.77
Direct access to site-specifically phosphorylated-lysine peptides from a solid-support. Org Biomol Chem (2015) 0.77
Highly conserved cysteines are involved in the oligomerization of occludin-redox dependency of the second extracellular loop. Antioxid Redox Signal (2013) 0.77
Association between segments of zonula occludens proteins: live-cell FRET and mass spectrometric analysis. Ann N Y Acad Sci (2012) 0.77
Purification and functional characterization of the full length recombinant Ebola virus VP35 protein expressed in E. coli. Protein Expr Purif (2009) 0.77
2-aminopurine enhances the oncolytic activity of an E1b-deleted adenovirus in hepatocellular carcinoma cells. PLoS One (2013) 0.76
Nitrogen dioxide induces apoptosis and proliferation but not emphysema in rat lungs. Thorax (2007) 0.75
Corrigendum: Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells. Sci Rep (2017) 0.75